We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEU icon
2676
NewMarket
NEU
$8.72B
$451K ﹤0.01%
1,318
-43
-3% -$16.3K
VER
2677
DELISTED
VEREIT, Inc.
VER
$451K ﹤0.01%
13,883
-978
-7% -$32.2K
CCS icon
2678
Century Communities
CCS
$2.04B
$450K ﹤0.01%
+10,636
New +$389K
SPHQ icon
2679
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
$450K ﹤0.01%
11,632
+468
+4% +$17.7K
EPP icon
2680
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
$449K ﹤0.01%
11,063
-1,349
-11% -$55.8K
CZR icon
2681
CALL
Caesars Entertainment
CZR
$6.04B
$448K ﹤0.01%
27,000
-1,600
-6% -$70.3K
ACH
2682
Accendra Health
ACH
$84.6M
$446K ﹤0.01%
17,769
-134
-0.7% -$1.95K
DOMO icon
2683
Domo
DOMO
$187M
$445K ﹤0.01%
11,601
-2,170
-16% -$78.2K
WRAP icon
2684
Wrap Technologies
WRAP
$97.4M
$445K ﹤0.01%
65,770
+53,115
+420% +$506K
APA icon
2685
APA Corp
APA
$14B
$444K ﹤0.01%
46,877
-6,574
-12% -$90K
FFIN icon
2686
First Financial Bankshares
FFIN
$5.04B
$444K ﹤0.01%
15,925
-704
-4% -$20.9K
WAFD icon
2687
WaFd
WAFD
$2.81B
$444K ﹤0.01%
21,264
-72,642
-77% -$1.71M
DOOR
2688
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$444K ﹤0.01%
4,511
-474
-10% -$42.1K
HLNE icon
2689
Hamilton Lane
HLNE
$5.91B
$443K ﹤0.01%
6,851
-4,411
-39% -$302K
NKTR icon
2690
Nektar Therapeutics
NKTR
$2.57B
$442K ﹤0.01%
1,778
-26
-1% -$8.18K
SBI
2691
Western Asset Intermediate Muni Fund
SBI
$109M
$442K ﹤0.01%
48,792
-110,616
-69% -$990K
CIZ
2692
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
$442K ﹤0.01%
15,868
-342
-2% -$9.53K
THC icon
2693
Tenet Healthcare
THC
$21.5B
$441K ﹤0.01%
18,002
-8,365
-32% -$214K
VRAY
2694
DELISTED
ViewRay, Inc.
VRAY
$441K ﹤0.01%
125,875
-200
-0.2% -$557
FPH icon
2695
Five Point Holdings
FPH
$372M
$439K ﹤0.01%
105,266
+81,201
+337% +$394K
MSTR icon
2696
Strategy Inc
MSTR
$38.2B
$439K ﹤0.01%
+29,140
New +$394K
WLK icon
2697
Westlake Corp
WLK
$10.2B
$439K ﹤0.01%
6,950
+2,844
+69% +$168K
IVOG icon
2698
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
$438K ﹤0.01%
5,874
-1,068
-15% -$78.9K
PCRX icon
2699
Pacira BioSciences
PCRX
$924M
$438K ﹤0.01%
7,282
+2,496
+52% +$145K
CDE icon
2700
Coeur Mining
CDE
$19B
$437K ﹤0.01%
59,270
-13,600
-19% -$102K

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.